FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205749137> ?p ?o ?g. }

• W4205749137 abstract "Abstract The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in late 2019, has caused a worldwide pandemic with unprecedented economic and societal impact. Currently, several vaccines are available, and multitudes of antiviral treatments have been proposed and tested. Although many of the vaccines show high clinical efficacy, they are not equally accessible worldwide. Additionally, due to the continuous emergence of new virus variants, and generally short duration of immunity, the development of safe and effective antiviral treatments remains of the utmost importance. Since the emergence of SARS-CoV-2, substantial efforts have been undertaken to repurpose existing and approved drugs for accelerated clinical testing and potential emergency use authorizations. However, drug-repurposing using high throughput screenings in cellular assays, often identify hits that later prove ineffective in clinical studies. Our approach was to evaluate the activity of compounds that have either been tested clinically or already undergone extensive preclinical profiling, using a standardized in vitro model of human nasal epithelium. Secondly, we evaluated drug combinations using sub-maximal doses of each active single compound. Here, we report the antiviral effects of 95 single compounds and 30 combinations. The data show that selected drug combinations including 10 μM of molnupiravir, a viral RNA-dependent RNA polymerase (RdRp) inhibitor, effectively inhibit SARS-CoV-2 replication. This indicates that such combinations are worthy of further evaluation as potential treatment strategies against coronavirus disease 2019 (COVID-19)." @default.
• W4205749137 created "2022-01-25" @default.
• W4205749137 creator A5003087042 @default.
• W4205749137 creator A5008798150 @default.
• W4205749137 creator A5020775571 @default.
• W4205749137 creator A5029945170 @default.
• W4205749137 creator A5032814977 @default.
• W4205749137 creator A5039757768 @default.
• W4205749137 creator A5040154818 @default.
• W4205749137 creator A5042500741 @default.
• W4205749137 creator A5053935202 @default.
• W4205749137 creator A5073274545 @default.
• W4205749137 creator A5074097531 @default.
• W4205749137 creator A5079458230 @default.
• W4205749137 creator A5080612237 @default.
• W4205749137 creator A5089302623 @default.
• W4205749137 date "2022-01-10" @default.
• W4205749137 modified "2023-10-18" @default.
• W4205749137 title "Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium <i>in vitro</i>" @default.
• W4205749137 cites W119403464 @default.
• W4205749137 cites W1989069389 @default.
• W4205749137 cites W2091991657 @default.
• W4205749137 cites W2138844071 @default.
• W4205749137 cites W2152544605 @default.
• W4205749137 cites W2256756668 @default.
• W4205749137 cites W2315025523 @default.
• W4205749137 cites W2318156787 @default.
• W4205749137 cites W2474614962 @default.
• W4205749137 cites W2742581645 @default.
• W4205749137 cites W2803131802 @default.
• W4205749137 cites W2807398791 @default.
• W4205749137 cites W2894600215 @default.
• W4205749137 cites W3001897055 @default.
• W4205749137 cites W3008827533 @default.
• W4205749137 cites W3009885589 @default.
• W4205749137 cites W3009906937 @default.
• W4205749137 cites W3010955108 @default.
• W4205749137 cites W3016288338 @default.
• W4205749137 cites W3021577619 @default.
• W4205749137 cites W3021841162 @default.
• W4205749137 cites W3027630905 @default.
• W4205749137 cites W3034095150 @default.
• W4205749137 cites W3036931136 @default.
• W4205749137 cites W3044711307 @default.
• W4205749137 cites W3045700994 @default.
• W4205749137 cites W3080981445 @default.
• W4205749137 cites W3096383810 @default.
• W4205749137 cites W3111068209 @default.
• W4205749137 cites W3114279766 @default.
• W4205749137 cites W3120589786 @default.
• W4205749137 cites W3123544697 @default.
• W4205749137 cites W3135420706 @default.
• W4205749137 cites W3158584109 @default.
• W4205749137 cites W3162323249 @default.
• W4205749137 cites W3164512669 @default.
• W4205749137 cites W3169466472 @default.
• W4205749137 cites W3169782252 @default.
• W4205749137 cites W3200454547 @default.
• W4205749137 doi "https://doi.org/10.1101/2022.01.10.475377" @default.
• W4205749137 hasPublicationYear "2022" @default.
• W4205749137 type Work @default.
• W4205749137 citedByCount "4" @default.
• W4205749137 countsByYear W42057491372022 @default.
• W4205749137 countsByYear W42057491372023 @default.
• W4205749137 crossrefType "posted-content" @default.
• W4205749137 hasAuthorship W4205749137A5003087042 @default.
• W4205749137 hasAuthorship W4205749137A5008798150 @default.
• W4205749137 hasAuthorship W4205749137A5020775571 @default.
• W4205749137 hasAuthorship W4205749137A5029945170 @default.
• W4205749137 hasAuthorship W4205749137A5032814977 @default.
• W4205749137 hasAuthorship W4205749137A5039757768 @default.
• W4205749137 hasAuthorship W4205749137A5040154818 @default.
• W4205749137 hasAuthorship W4205749137A5042500741 @default.
• W4205749137 hasAuthorship W4205749137A5053935202 @default.
• W4205749137 hasAuthorship W4205749137A5073274545 @default.
• W4205749137 hasAuthorship W4205749137A5074097531 @default.
• W4205749137 hasAuthorship W4205749137A5079458230 @default.
• W4205749137 hasAuthorship W4205749137A5080612237 @default.
• W4205749137 hasAuthorship W4205749137A5089302623 @default.
• W4205749137 hasBestOaLocation W42057491371 @default.
• W4205749137 hasConcept C103637391 @default.
• W4205749137 hasConcept C126322002 @default.
• W4205749137 hasConcept C159047783 @default.
• W4205749137 hasConcept C18903297 @default.
• W4205749137 hasConcept C202751555 @default.
• W4205749137 hasConcept C203014093 @default.
• W4205749137 hasConcept C2779134260 @default.
• W4205749137 hasConcept C2779756493 @default.
• W4205749137 hasConcept C2780035454 @default.
• W4205749137 hasConcept C3007834351 @default.
• W4205749137 hasConcept C3008058167 @default.
• W4205749137 hasConcept C519536355 @default.
• W4205749137 hasConcept C524204448 @default.
• W4205749137 hasConcept C55493867 @default.
• W4205749137 hasConcept C71924100 @default.
• W4205749137 hasConcept C86803240 @default.
• W4205749137 hasConcept C89623803 @default.
• W4205749137 hasConcept C98274493 @default.
• W4205749137 hasConceptScore W4205749137C103637391 @default.
• W4205749137 hasConceptScore W4205749137C126322002 @default.

• next